Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at capecitabine after surgery for cancer of the bile duct or gallbladder (BILCAP)

Overview

Cancer types:

Bile duct cancer, Biliary tree cancers, Gallbladder cancer

Status:

Results

Phase:

Phase 3

Details

This trial compared surgery and capecitabine with surgery alone for cancer of the bile duct or gallbladder (also called biliary tract cancer).

Cancer Research UK supported this trial.

This trial was open for people to join between March 2006 and December 2014. The results were published in 2019.

Recruitment start: 16 March 2006

Recruitment end: 31 December 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor John Primrose

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

University of Southampton

Cancer Research UK Clinical Trials Unit, University of Birmingham

Other information

This is Cancer Research UK trial number CRUK/05/002.

Last reviewed: 5 August 2019

CRUK internal database number: 481

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.